posted on 2022-07-30, 16:03authored byPaul Gehrtz, Shir Marom, Mike Bührmann, Julia Hardick, Silke Kleinbölting, Amit Shraga, Christian Dubiella, Ronen Gabizon, Jan N. Wiese, Matthias P. Müller, Galit Cohen, Ilana Babaev, Khriesto Shurrush, Liat Avram, Efrat Resnick, Haim Barr, Daniel Rauh, Nir London
High-throughput nanomole-scale synthesis allows for late-stage
functionalization (LSF) of compounds in an efficient and economical
manner. Here, we demonstrated that copper-catalyzed azide–alkyne
cycloaddition could be used for the LSF of covalent kinase inhibitors
at the nanoscale, enabling the synthesis of hundreds of compounds
that did not require purification for biological assay screening,
thus reducing experimental time drastically. We generated crude libraries
of inhibitors for the kinase MKK7, derived from two different parental
precursors, and analyzed them via the high-throughput
In-Cell Western assay. Select inhibitors were resynthesized, validated via conventional biological and biochemical methods such
as western blots and liquid chromatography–mass spectrometry
(LC-MS) labeling, and successfully co-crystallized. Two of these compounds
showed over 20-fold increased inhibitory activity compared to the
parental compound. This study demonstrates that high-throughput LSF
of covalent inhibitors at the nanomole-scale level can be an auspicious
approach in improving the properties of lead chemical matter.